BioCentury | Sep 7, 2015
Clinical News

greenovation preclinical data

...Inherited Metabolic Diseases. The product is a recombinant human non-phosphorylated alpha-galactosidase A produced in moss. greenovation...
BioCentury | Nov 3, 2014
Company News

greenovation endocrine/metabolic news

...world's first GMP-compliant batch of drug substance manufactured in moss for clinical use. The substance, greenovation's...
...treat Fabry's disease. greenovation uses its eukaryotic Physcomitrella-based BryoTechnology platform to develop custom protein biopharmaceuticals. greenovation...
BioCentury | May 12, 2014
Company News

greenovation management update

greenovation Biotech GmbH , Freiburg, Germany Business: Supply/Service, Endocrine/Metabolic Hired: Andreas Hartmann as CBO WIR Staff...
BioCentury | Jun 9, 2008
Company News

Arana, CSL, greenovation Biotech GmbH deal

...CSL after development of the first humanized candidate (see BioCentury, Feb. 11). Separately, Arana and greenovation...
...Arana will use its Superhumanization and EvoGene protein engineering technologies to generate optimized drug candidates. greenovation...
...not disclosed. Arana Therapeutics Ltd. (ASX:AAH; LSE:AAHX), North Ryde, Australia CSL Ltd. (ASX:CSL), Melbourne, Australia greenovation...
BioCentury | Nov 24, 2003
Company News

greenovation Biotech GmbH, The Dow Chemical Co. deal

...in plants. greenovation will license IP from DOW covering modifications of glycosylation patterns in plants. greenovation...
...plant-specific sugar residues in moss. DOW will receive greenovation's data on the work in moss. greenovation...
BioCentury | Nov 19, 2003
Company News

greenovation, Dow glycosylation deal

...in plants. greenovation will license IP from DOW covering modifications of glycosylation patterns in plants. greenovation...
...greenovation will use its double-knock-out technology on plant-specific sugar residues in moss. DOW will receive greenovation's...
BioCentury | Aug 7, 2000
Company News

Pharmacia agbio/veterinary/environmental news

...inventors of golden rice at the Swiss Federal Institute of Technology announced a collaboration with Greenovation...
BioCentury | Aug 4, 2000
Company News

Monsanto backs humanitarian golden rice effort

...inventors of golden rice at the Swiss Federal Institute of Technology announced a collaboration with Greenovation...
BioCentury | May 22, 2000
Company News

AstraZeneca, Greenovation Pflanzenbiotechnologie GmbH deal

...AZN received an exclusive license from Greenovation to Golden Rice, a genetically modified rice with high...
...be available for local planting and consumption in 2003. AstraZeneca plc (LSE:AZN; AZN), London, U.K. Greenovation...
BioCentury | May 16, 2000
Company News

AstraZeneca GMO rice collaboration

AZN received an exclusive license to Golden Rice, a genetically modified rice with high levels of beta-carotene, developed by the Swiss Federal Institute of Technology. The rice was licensed from Greenovations (Freiburg, Germany), a company...
Items per page:
1 - 10 of 10
BioCentury | Sep 7, 2015
Clinical News

greenovation preclinical data

...Inherited Metabolic Diseases. The product is a recombinant human non-phosphorylated alpha-galactosidase A produced in moss. greenovation...
BioCentury | Nov 3, 2014
Company News

greenovation endocrine/metabolic news

...world's first GMP-compliant batch of drug substance manufactured in moss for clinical use. The substance, greenovation's...
...treat Fabry's disease. greenovation uses its eukaryotic Physcomitrella-based BryoTechnology platform to develop custom protein biopharmaceuticals. greenovation...
BioCentury | May 12, 2014
Company News

greenovation management update

greenovation Biotech GmbH , Freiburg, Germany Business: Supply/Service, Endocrine/Metabolic Hired: Andreas Hartmann as CBO WIR Staff...
BioCentury | Jun 9, 2008
Company News

Arana, CSL, greenovation Biotech GmbH deal

...CSL after development of the first humanized candidate (see BioCentury, Feb. 11). Separately, Arana and greenovation...
...Arana will use its Superhumanization and EvoGene protein engineering technologies to generate optimized drug candidates. greenovation...
...not disclosed. Arana Therapeutics Ltd. (ASX:AAH; LSE:AAHX), North Ryde, Australia CSL Ltd. (ASX:CSL), Melbourne, Australia greenovation...
BioCentury | Nov 24, 2003
Company News

greenovation Biotech GmbH, The Dow Chemical Co. deal

...in plants. greenovation will license IP from DOW covering modifications of glycosylation patterns in plants. greenovation...
...plant-specific sugar residues in moss. DOW will receive greenovation's data on the work in moss. greenovation...
BioCentury | Nov 19, 2003
Company News

greenovation, Dow glycosylation deal

...in plants. greenovation will license IP from DOW covering modifications of glycosylation patterns in plants. greenovation...
...greenovation will use its double-knock-out technology on plant-specific sugar residues in moss. DOW will receive greenovation's...
BioCentury | Aug 7, 2000
Company News

Pharmacia agbio/veterinary/environmental news

...inventors of golden rice at the Swiss Federal Institute of Technology announced a collaboration with Greenovation...
BioCentury | Aug 4, 2000
Company News

Monsanto backs humanitarian golden rice effort

...inventors of golden rice at the Swiss Federal Institute of Technology announced a collaboration with Greenovation...
BioCentury | May 22, 2000
Company News

AstraZeneca, Greenovation Pflanzenbiotechnologie GmbH deal

...AZN received an exclusive license from Greenovation to Golden Rice, a genetically modified rice with high...
...be available for local planting and consumption in 2003. AstraZeneca plc (LSE:AZN; AZN), London, U.K. Greenovation...
BioCentury | May 16, 2000
Company News

AstraZeneca GMO rice collaboration

AZN received an exclusive license to Golden Rice, a genetically modified rice with high levels of beta-carotene, developed by the Swiss Federal Institute of Technology. The rice was licensed from Greenovations (Freiburg, Germany), a company...
Items per page:
1 - 10 of 10